Aggressive and advanced metastatic cancers have limited treatment options and poor survival. TR Beta Oncology (TRBO) is pioneering targeted therapeutics that selectively activate thyroid hormone receptor beta. At TRBO, our mission is to deliver smarter, safer, more durable cancer treatments and define a new therapeutic class in oncology.